the same.
the effect of generic drugs is the same as that of original drugs. Otherwise, the relevant state departments dare not approve the production and listing, and enter the medical industry.
rivaroxaban is not a medicine for health care or anything. It is a life-saving medicine for preventing and treating deep vein thrombosis, pulmonary embolism caused by it and cardiovascular and cerebrovascular diseases. Life-saving medicine, this dare not mess around. Two years ago, I had bilateral hip replacement twice.
The rivaroxaban was used after operation. Two pharmaceutical companies in China have copied this medicine, so you can use it boldly if the doctor prescribes it.
after my operation that year, according to my will, I used the rivaroxaban of Berrito. Quite expensive! This thing can't be reimbursed. It's almost in 4 yuan, so you have to pay for it at your own expense. This medicine, the surgical hospital can not enter the medical insurance, there is no such medicine. It is also bought by big pharmacies or private hospitals.
it's quite a big box with several foreign language instructions in it, which is quite thick. There are only five tablets, the same size as medicinal vitamin C tablets. It's a big medicine box, just five small tablets, orange or orange, or a color between the two colors. I can't describe his color accurately. The problem is that you have to eat this stuff for more than a month and five weeks after operation.
domestic products are definitely much cheaper, so don't have a problem with money.
bairuituo (rivaroxaban tablets), produced by Bayer medical care co., ltd, has the following clinical indications:
1. It is used for adult patients undergoing elective hip or knee replacement surgery to prevent venous thrombosis (VTE).
2. It can be used to treat adult venous thrombosis (DVT) and reduce the risk of DVT recurrence and pulmonary embolism (PE) after acute DVT.
3. For adult patients with nonvalvular atrial fibrillation who have one or more risk factors (such as congestive heart failure, hypertension, age ≥75 years, diabetes, stroke or transient ischemic attack), so as to reduce the risk of stroke and systemic embolism.
for the above contents, please refer to Baidu Encyclopedia-Bairuituo.